companydata.dkcompanydata.dk

MATRIX PHARMACEUTICALS ApS: Financial statements 2017

CVR: 29625867

Source: annual report 2017, Danish Business Authority

01/01/201731/12/2017

MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 266,980 and a net result of DKK -368,860 compared with DKK -337,843 the year before. Equity in the 2017 report amounted to DKK -1,237,522.

Gross Profit
DKK 266,980
Profit/Loss
DKK -368,860
Equity
DKK -1,237,522
Total Assets
DKK 2,190,800

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-267 t.-369 t.-1.2 mio.-
2016--40 t.-338 t.459 t.-
2015-450 t.211 t.797 t.-
2014-929 t.754 t.587 t.-
20138.6 mio.1.2 mio.961 t.-167 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on MATRIX PHARMACEUTICALS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

MATRIX PHARMACEUTICALS ApS: The 2016 annual report is outMay 31, 2017

MATRIX PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK -39,517, and the net result was DKK -337,843.

About MATRIX PHARMACEUTICALS ApS

MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.

Source: annual report 2025, Danish Business Authority